Recursion Pharma is combining high-throughput experimental biology, bioinformatics, and machine learning to rapidly identify new indications for many known drugs and shelved assets. The company completed its IPO [NASDAQ: RXRX] in 2021.

Recursion Pharma is a Salt Lake City-based drug discovery company founded in 2013 based on technology developed at the University of Utah. Recursion uses a novel drug screening platform to efficiently reposition known drugs and shelved pharmaceutical assets to treat rare genetic diseases and other conditions.

• Industry

  • AI & Machine Learning
  • Biotechnology
  • Health + Tech

• Milestones

  • Lux investment: 2016
  • IPO: 2021

• Founders

  • Chris Gibson, PhD
  • Blake Borgeson, PhD
  • Dean Li, PhD

  LUX Partners

  • Zavain Dar

• Latest Tweets

  • Women of #SLC — we’re sponsoring the “Every Woman A Leader” event tonight at the @UUtah Cleone Peterson Eccles Alum… https://t.co/30mg8tkZiS@RecursionPharma - 21h
  • Here is a sentence EH&S professionals almost never see in a job posting: Build out a multi-site, international lab… https://t.co/k1q7wliF7T@RecursionPharma - 03:31 PM May 20th
  • After kicking off our collaboration a few months ago, we were overjoyed to welcome our partners at @Roche &… https://t.co/twYoNtRTK6@RecursionPharma - 07:24 PM May 19th